Abstract
The incidence of human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCC) has dramatically increased in recent decades. There is clear evidence in literature that patients with HPV-positive HNSCC have a significantly better prognosis after genotoxic therapies compared to those with HPV-negative HNSCC. This favorable outcome has been associated with distinct features in DNA damage repair (DDR) functions specific to HPV-positive HNSCC. As a result, weaknesses in DDR have been identified for both HPV-positive and HPV-negative HNSCC, respectively. Therefore, personalized therapy targeting the vulnerable aspects of DDR pathways based on HPV status and mutational profiles has been proposed for precise treatment of HNSCC patients. This review focuses on the most recent evidence regarding the impact of HPV on DDR pathways and the related therapeutic strategies in HNSCC. We anticipate that future translation of these discoveries into clinical practice may lead to treatment de-escalation approaches in HPV-positive HNSCC and more effective therapies for the poor prognosis HPV-negative HNSCC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data generated in the present study may be requested from the corresponding author (malin2021@szu.edu.cn).
References
Alsahafi, E. N., Thavaraj, S., Sarvestani, N., Novoplansky, O., Elkabets, M., Ayaz, B., Tavassoli, M., & Legends, M. F. (2021). EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation. Cancer Letters, 498, 80–97. https://doi.org/10.1016/j.canlet.2020.10.035
Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tan, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., & Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medicine, 363(1), 24–35. https://doi.org/10.1056/NEJMoa0912217
Basukala, O., & Banks, L. (2021). The not-so-good, the bad and the ugly: HPV E5, E6 and E7 oncoproteins in the orchestration of carcinogenesis. Viruses, 13(10), 1892. https://doi.org/10.3390/v13101892
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., Ove, R., Kies, M. S., Baselga, J., Youssoufian, H., Amellal, N., Rowinsky, E. K., & Ang, K. K. (2006). Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 354(6), 567–578. https://doi.org/10.1056/NEJMoa053422
Busch, C. J., Kroger, M. S., Jensen, J., Kriegs, M., Gatzemeier, F., Petersen, C., Munscher, A., Rothkamm, K., & Rieckmann, T. (2017). G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1. Radiotherapy and Oncology, 122(2), 260–266. https://doi.org/10.1016/j.radonc.2016.11.017
Castellsague, X., Alemany, L., Quer, M., Halec, G., Quiros, B., Tous, S., Clavero, O., Alos, L., Biegner, T., Szafarowski, T., Alejo, M., Holzinger, D., Cadena, E., Claros, E., Hall, G., Laco, J., Poljak, M., Benevolo, M., Kasamatsu, E., … Neck Cancer Study G. (2016). HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. Journal of National Cancer Institute, 108(6), djv403. https://doi.org/10.1093/jnci/djv403
Citro, S., Miccolo, C., Medda, A., Ghiani, L., Tagliabue, M., Ansarin, M., & Chiocca, S. (2022). HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer. Journal of Experimental & Clinical Cancer Research, 41(1), 59. https://doi.org/10.1186/s13046-022-02258-9
de Martel, C., Plummer, M., Vignat, J., & Franceschi, S. (2017). Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer, 141(4), 664–670. https://doi.org/10.1002/ijc.30716
Deans, A. J., & West, S. C. (2011). DNA interstrand crosslink repair and cancer. Nature Reviews Cancer, 11(7), 467–480. https://doi.org/10.1038/nrc3088
Dok, R., Glorieux, M., Bamps, M., & Nuyts, S. (2021). Effect of ATR inhibition in RT response of HPV-negative and HPV-positive head and neck cancers. International Journal of Molecular Sciences, 22(4), 1504. https://doi.org/10.3390/ijms22041504
Dok, R., Kalev, P., Van Limbergen, E. J., Asbagh, L. A., Vazquez, I., Hauben, E., Sablina, A., & Nuyts, S. (2014). p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors. Cancer Research, 74(6), 1739–1751. https://doi.org/10.1158/0008-5472.CAN-13-2479
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012). The biology and life-cycle of human papillomaviruses. Vaccine, 30(Suppl 5), F55–F70. https://doi.org/10.1016/j.vaccine.2012.06.083
Fabbrizi, M. R., & Parsons, J. L. (2020). Radiotherapy and the cellular DNA damage response: Current and future perspectives on head and neck cancer treatment. Cancer Drug Resistance, 3(4), 775–790. https://doi.org/10.20517/cdr.2020.49
Faulhaber, E. M., Jost, T., Symank, J., Scheper, J., Burkel, F., Fietkau, R., Hecht, M., & Distel, L. V. (2021). Kinase inhibitors of DNA-PK, ATM and ATR in combination with ionizing radiation can increase tumor cell death in HNSCC cells while sparing normal tissue cells. Genes (basel), 12(6), 925. https://doi.org/10.3390/genes12060925
Fishel, R. (2015). Mismatch repair. Journal of Biological Chemistry, 290(44), 26395–26403. https://doi.org/10.1074/jbc.R115.660142
Frederick, B. A., Gupta, R., Atilano-Roque, A., Su, T. T., & Raben, D. (2020). Combined EGFR1 and PARP1 inhibition enhances the effect of radiation in head and neck squamous cell carcinoma models. Radiation Research, 194(5), 519–531. https://doi.org/10.1667/RR15480.1
Fu, E., Liu, T., Yu, S., Chen, X., Song, L., Lou, H., Ma, F., Zhang, S., Hussain, S., Guo, J., Sun, J., Yu, P., Mao, X., & Wei, L. (2020). M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB-EGF. Oncology Reports, 44(2), 698–710. https://doi.org/10.3892/or.2020.7628
Gabani, P., Lin, A. J., Barnes, J., Oppelt, P., Adkins, D. R., Rich, J. T., Zevallos, J. P., Daly, M. D., Gay, H. A., & Thorstad, W. L. (2019). Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma. Radiotherapy and Oncology, 134, 81–88. https://doi.org/10.1016/j.radonc.2019.01.016
Glorieux, M., Dok, R., & Nuyts, S. (2020). The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells. Science and Reports, 10(1), 16208. https://doi.org/10.1038/s41598-020-73249-z
Grundy, G. J., & Parsons, J. L. (2020). Base excision repair and its implications to cancer therapy. Essays in Biochemistry, 64(5), 831–843. https://doi.org/10.1042/EBC20200013
Guix, I., Liu, Q., Pujana, M. A., Ha, P., Piulats, J., Linares, I., Guedea, F., Mao, J. H., Lazar, A., Chapman, J., Yom, S. S., Ashworth, A., & Barcellos-Hoff, M. H. (2022). Validation of anti-correlated TGFbeta signaling and alternative end-joining DNA repair signatures that predict response to genotoxic cancer therapy. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-21-2846
Hintelmann, K., Berenz, T., Kriegs, M., Christiansen, S., Gatzemeier, F., Struve, N., Petersen, C., Betz, C., Rothkamm, K., Oetting, A., & Rieckmann, T. (2021). Dual inhibition of PARP and the intra-S/G2 cell cycle checkpoints results in highly effective radiosensitization of HPV-positive HNSCC cells. Frontiers in Oncology, 11, 683688. https://doi.org/10.3389/fonc.2021.683688
Hu, C., Bugbee, T., Gamez, M., & Wallace, N. A. (2020). Beta human papillomavirus 8E6 attenuates non-homologous end joining by hindering DNA-PKcs activity. Cancers (basel), 12(9), 2356. https://doi.org/10.3390/cancers12092356
Huang, C., Chen, L., Savage, S. R., Eguez, R. V., Dou, Y., Li, Y., da Veiga, L. F., Jaehnig, E. J., Lei, J. T., Wen, B., Schnaubelt, M., Krug, K., Song, X., Cieslik, M., Chang, H. Y., Wyczalkowski, M. A., Li, K., Colaprico, A., Li, Q. K., … Clinical Proteomic Tumor Analysis C. (2021). Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. Cancer Cell, 39(3), 361-379 e316. https://doi.org/10.1016/j.ccell.2020.12.007
Huang, Z., Chen, Y., Chen, R., Zhou, B., Wang, Y., Hong, L., Wang, Y., Wang, J., Xu, X., Huang, Z., & Chen, W. (2022). HPV enhances HNSCC chemosensitization by inhibiting SERPINB3 expression to disrupt the Fanconi anemia pathway. Adv Sci (Weinh), 10(1), e2202437. https://doi.org/10.1002/advs.202202437
Husain, H., Psyrri, A., Markovic, A., Rampias, T., Pectasides, E., Wang, H., Slebos, R., Yarbrough, W. G., Burtness, B., & Chung, C. H. (2012). Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. The Laryngoscope, 122(12), 2762–2768. https://doi.org/10.1002/lary.23647
Karukonda, P., Odhiambo, D., & Mowery, Y. M. (2022). Pharmacologic inhibition of ataxia telangiectasia and Rad3-related (ATR) in the treatment of head and neck squamous cell carcinoma. Molecular Carcinogenesis, 61(2), 225–238. https://doi.org/10.1002/mc.23384
Keam, B., Machiels, J. P., Kim, H. R., Licitra, L., Golusinski, W., Gregoire, V., Lee, Y. G., Belka, C., Guo, Y., Rajappa, S. J., Tahara, M., Azrif, M., Ang, M. K., Yang, M. H., Wang, C. H., Ng, Q. S., Wan Zamaniah, W. I., Kiyota, N., Babu, S., … Pentheroudakis, G. (2021). Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck. ESMO Open, 6(6), 100309. https://doi.org/10.1016/j.esmoop.2021.100309
Khanal, S., & Galloway, D. A. (2019). High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2. PLoS Pathogens, 15(2), e1007442. https://doi.org/10.1371/journal.ppat.1007442
Kimple, R. J., Smith, M. A., Blitzer, G. C., Torres, A. D., Martin, J. A., Yang, R. Z., Peet, C. R., Lorenz, L. D., Nickel, K. P., Klingelhutz, A. J., Lambert, P. F., & Harari, P. M. (2013). Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Research, 73(15), 4791–4800. https://doi.org/10.1158/0008-5472.CAN-13-0587
Kirshner, J., Jobling, M. F., Pajares, M. J., Ravani, S. A., Glick, A. B., Lavin, M. J., Koslov, S., Shiloh, Y., & Barcellos-Hoff, M. H. (2006). Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Research, 66(22), 10861–10869. https://doi.org/10.1158/0008-5472.CAN-06-2565
Kitamura, N., Sento, S., Yoshizawa, Y., Sasabe, E., Kudo, Y., & Yamamoto, T. (2020). Current trends and future prospects of molecular targeted therapy in head and neck squamous cell carcinoma. International Journal of Molecular Sciences, 22(1), 240. https://doi.org/10.3390/ijms22010240
Kocher, S., Zech, H. B., Krug, L., Gatzemeier, F., Christiansen, S., Meyer, F., Rietow, R., Struve, N., Mansour, W. Y., Kriegs, M., Petersen, C., Betz, C., Rothkamm, K., & Rieckmann, T. (2022). A lack of effectiveness in the ATM-orchestrated DNA damage response contributes to the DNA repair defect of HPV-positive head and neck cancer cells. Frontiers in Oncology, 12, 765968. https://doi.org/10.3389/fonc.2022.765968
Krishnamurthy, S., Ahmed, I., Bhise, R., Mohanti, B. K., Sharma, A., Rieckmann, T., Paterson, C., & Bonomo, P. (2022). The dogma of cetuximab and radiotherapy in head and neck cancer—A dawn to dusk journey. Clinical and Translational Radiation Oncology, 34, 75–81. https://doi.org/10.1016/j.ctro.2022.03.009
Leeman, J. E., Li, Y., Bell, A., Hussain, S. S., Majumdar, R., Rong-Mullins, X., Blecua, P., Damerla, R., Narang, H., Ravindran, P. T., Lee, N. Y., Riaz, N., Powell, S. N., & Higginson, D. S. (2019). Human papillomavirus 16 promotes microhomology-mediated end-joining. Proceedings of the National Academy of Sciences of the United States of America, 116(43), 21573–21579. https://doi.org/10.1073/pnas.1906120116
Leemans, C. R., Braakhuis, B. J., & Brakenhoff, R. H. (2011). The molecular biology of head and neck cancer. Nature Reviews Cancer, 11(1), 9–22. https://doi.org/10.1038/nrc2982
Leonard, B. C., Lee, E. D., Bhola, N. E., Li, H., Sogaard, K. K., Bakkenist, C. J., Grandis, J. R., & Johnson, D. E. (2019). ATR inhibition sensitizes HPV(−) and HPV(+) head and neck squamous cell carcinoma to cisplatin. Oral Oncology, 95, 35–42. https://doi.org/10.1016/j.oraloncology.2019.05.028
Li, G. M. (2008). Mechanisms and functions of DNA mismatch repair. Cell Research, 18, 85–98. https://doi.org/10.1038/cr.2007.115
Lilja-Fischer, J. K., Ulhoi, B. P., Alsner, J., Stougaard, M., Thomsen, M. S., Busk, M., Lassen, P., Steiniche, T., Nielsen, V. E., & Overgaard, J. (2019). Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts. Acta Oncologica, 58(10), 1489–1494. https://doi.org/10.1080/0284186X.2019.1660802
Lindemann, A., Patel, A. A., Tang, L., Tanaka, N., Gleber-Netto, F. O., Bartels, M. D., Wang, L., McGrail, D. J., Lin, S. Y., Frank, S. J., Frederick, M. J., Myers, J. N., & Osman, A. A. (2021). Combined inhibition of Rad51 and Wee1 enhances cell killing in HNSCC through induction of apoptosis associated with excessive DNA damage and replication stress. Molecular Cancer Therapeutics, 20(7), 1257–1269. https://doi.org/10.1158/1535-7163.MCT-20-0252
Liu, Q., Chen, G., Moore, J., Guix, I., Placantonakis, D., & Barcellos-Hoff, M. H. (2022a). Exploiting canonical TGFbeta signaling in cancer treatment. Molecular Cancer Therapeutics, 21(1), 16–24. https://doi.org/10.1158/1535-7163.MCT-20-0891
Liu, Q., Gheorghiu, L., Drumm, M., Clayman, R., Eidelman, A., Wszolek, M. F., Olumi, A., Feldman, A., Wang, M., Marcar, L., Citrin, D. E., Wu, C. L., Benes, C. H., Efstathiou, J. A., & Willers, H. (2018a). PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53. Oncogene, 37(21), 2793–2805. https://doi.org/10.1038/s41388-018-0130-6
Liu, Q., Lopez, K., Murnane, J., Humphrey, T., & Barcellos-Hoff, M. H. (2019). Misrepair in context: TGFbeta regulation of DNA repair. Frontiers in Oncology, 9, 799. https://doi.org/10.3389/fonc.2019.00799
Liu, Q., Ma, L., Jones, T., Palomero, L., Pujana, M. A., Martinez-Ruiz, H., Ha, P. K., Murnane, J., Cuartas, I., Seoane, J., Baumann, M., Linge, A., & Barcellos-Hoff, M. H. (2018b). Subjugation of TGFbeta signaling by human papilloma virus in head and neck squamous cell carcinoma shifts DNA repair from homologous recombination to alternative end joining. Clinical Cancer Research, 24(23), 6001–6014. https://doi.org/10.1158/1078-0432.CCR-18-1346
Liu, Q., Palomero, L., Moore, J., Guix, I., Espin, R., Aytes, A., Mao, J. H., Paulovich, A. G., Whiteaker, J. R., Ivey, R. G., Iliakis, G., Luo, D., Chalmers, A. J., Murnane, J., Pujana, M. A., & Barcellos-Hoff, M. H. (2021). Loss of TGFbeta signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types. Science Translational Medicine, 13(580), eabc4465. https://doi.org/10.1126/scitranslmed.abc4465
Liu, T., Ma, L., Song, L., Yan, B., Zhang, S., Wang, B., Zuo, N., Sun, X., Deng, Y., Ren, Q., Li, Y., Zhou, J., Liu, Q., & Wei, L. (2022b). CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma. Oral Oncology, 129, 105858. https://doi.org/10.1016/j.oraloncology.2022.105858
Lohaus, F., Linge, A., Tinhofer, I., Budach, V., Gkika, E., Stuschke, M., Balermpas, P., Rodel, C., Avlar, M., Grosu, A. L., Abdollahi, A., Debus, J., Bayer, C., Belka, C., Pigorsch, S., Combs, S. E., Monnich, D., Zips, D., von Neubeck, C., … Dktk, R. O. G. (2014). HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and Oncology, 113(3), 317–323. https://doi.org/10.1016/j.radonc.2014.11.011
Martinez-Ruiz, H., Illa-Bochaca, I., Omene, C., Hanniford, D., Liu, Q., Hernando, E., & Barcellos-Hoff, M. H. (2016). A TGFbeta-miR-182-BRCA1 axis controls the mammary differentiation hierarchy. Science Signal, 9(457), ra118. https://doi.org/10.1126/scisignal.aaf5402
Maufort, J. P., Shai, A., Pitot, H. C., & Lambert, P. F. (2010). A role for HPV16 E5 in cervical carcinogenesis. Cancer Research, 70(7), 2924–2931. https://doi.org/10.1158/0008-5472.CAN-09-3436
McBride, A. A. (2022). Human papillomaviruses: diversity, infection and host interactions. Nature Reviews Microbiology, 20(2), 95–108. https://doi.org/10.1038/s41579-021-00617-5
Molkentine, D. P., Molkentine, J. M., Bridges, K. A., Valdecanas, D. R., Dhawan, A., Bahri, R., Hefner, A. J., Kumar, M., Yang, L., Abdelhakiem, M., Pifer, P. M., Sandulache, V., Sheth, A., Beadle, B. M., Thames, H. D., Mason, K. A., Pickering, C. R., Meyn, R. E., & Skinner, H. D. (2022). p16 represses DNA damage repair via a novel ubiquitin-dependent signaling cascade. Cancer Research, 82(5), 916–928. https://doi.org/10.1158/0008-5472.CAN-21-2101
Molkentine, J. M., Molkentine, D. P., Bridges, K. A., Xie, T., Yang, L., Sheth, A., Heffernan, T. P., Clump, D. A., Faust, A. Z., Ferris, R. L., Myers, J. N., Frederick, M. J., Mason, K. A., Meyn, R. E., Pickering, C. R., & Skinner, H. D. (2021). Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints. International Journal of Radiation Biology, 97(8), 1121–1128. https://doi.org/10.1080/09553002.2020.1730014
Myllynen, L., Kwiatkowski, M., Gleissner, L., Riepen, B., Hoffer, K., Wurlitzer, M., Petersen, C., Dikomey, E., Rothkamm, K., Schluter, H., & Kriegs, M. (2015). Quantitative proteomics unveiled: regulation of DNA double strand break repair by EGFR involves PARP1. Radiotherapy and Oncology, 116(3), 423–430. https://doi.org/10.1016/j.radonc.2015.09.018
Parfenov, M., Pedamallu, C. S., Gehlenborg, N., Freeman, S. S., Danilova, L., Bristow, C. A., Lee, S., Hadjipanayis, A. G., Ivanova, E. V., Wilkerson, M. D., Protopopov, A., Yang, L., Seth, S., Song, X., Tang, J., Ren, X., Zhang, J., Pantazi, A., Santoso, N., … Cancer Genome Atlas N. (2014). Characterization of HPV and host genome interactions in primary head and neck cancers. Proceedings of the National Academy of Sciences of the United States of America, 111(43), 15544–15549. https://doi.org/10.1073/pnas.1416074111
Patterson-Fortin, J., & D’Andrea, A. D. (2020). Exploiting the microhomology-mediated end-joining pathway in cancer therapy. Cancer Research, 80(21), 4593–4600. https://doi.org/10.1158/0008-5472.CAN-20-1672
Schotz, U., Balzer, V., Brandt, F. W., Ziemann, F., Subtil, F. S. B., Rieckmann, T., Kocher, S., Engenhart-Cabillic, R., Dikomey, E., Wittig, A., & Arenz, A. (2020). Dual PI3K/mTOR inhibitor NVP-BEZ235 enhances radiosensitivity of head and neck squamous cell carcinoma (HNSCC) cell lines due to suppressed double-strand break (DSB) repair by non-homologous end joining. Cancers (basel), 12(2), 467. https://doi.org/10.3390/cancers12020467
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Tomaic, V. (2016). Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites. Cancers (basel), 8(10), 95. https://doi.org/10.3390/cancers8100095
Vitti, E. T., Kacperek, A., & Parsons, J. L. (2020). Targeting DNA double-strand break repair enhances radiosensitivity of HPV-positive and HPV-negative head and neck squamous cell carcinoma to photons and protons. Cancers (basel), 12(6), 1490. https://doi.org/10.3390/cancers12061490
Wang, L., Cao, J., Wang, X., Lin, E., Wang, Z., Li, Y., Li, Y., Chen, M., Wang, X., Jiang, B., Zhang, R., Sahoo, N., Zhang, X., Zhu, X. R., Myers, J. N., & Frank, S. J. (2020). Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells. Head and Neck, 42(9), 2244–2256. https://doi.org/10.1002/hed.26155
Weaver, A. N., Cooper, T. S., Rodriguez, M., Trummell, H. Q., Bonner, J. A., Rosenthal, E. L., & Yang, E. S. (2015). DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma. Oncotarget, 6(29), 26995–27007. https://doi.org/10.18632/oncotarget.4863
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015). FDA-approved small-molecule kinase inhibitors. Trends in Pharmacological Sciences, 36(7), 422–439. https://doi.org/10.1016/j.tips.2015.04.005
Zech, H. B., Berger, J., Mansour, W. Y., Nordquist, L., von Bargen, C. M., Bussmann, L., Oetting, A., Christiansen, S., Mockelmann, N., Bottcher, A., Busch, C. J., Petersen, C., Betz, C., Rothkamm, K., Kriegs, M., Kocher, S., & Rieckmann, T. (2022). Patient derived ex vivo tissue slice cultures demonstrate a profound DNA double-strand break repair defect in HPV-positive oropharyngeal head and neck cancer. Radiotherapy and Oncology, 168, 138–146. https://doi.org/10.1016/j.radonc.2022.01.017
Zeng, L., Nikolaev, A., Xing, C., Della Manna, D. L., & Yang, E. S. (2020). CHK1/2 inhibitor prexasertib suppresses NOTCH signaling and enhances cytotoxicity of cisplatin and radiation in head and neck squamous cell carcinoma. Molecular Cancer Therapeutics, 19(6), 1279–1288. https://doi.org/10.1158/1535-7163.MCT-19-0946
Zuo, N., Ma, L., Liu, T., Hu, W., Luo, Y., Meng, H., Ren, Q., Deng, Y., Wei, L., & Liu, Q. (2023). Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma. Oral Oncology, 140, 106367. https://doi.org/10.1016/j.oraloncology.2023.106367
Funding
National Natural Science Foundation of China, 82073007, Qi Liu, 82203967, Lin Ma, 82373212, Qi Liu, Basic and Applied Basic Research Foundation of Guangdong Province, 2023A1515011945, Lin Ma, Shenzhen Research and Development Program, JCYJ20210324131607019, Lanlan Wei.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Liu, Q., Zuo, N., Li, X. et al. Novel insights into DNA damage repair defects in HPV-positive head and neck squamous cell carcinoma: from the molecular basis to therapeutic opportunities. GENOME INSTAB. DIS. 4, 255–265 (2023). https://doi.org/10.1007/s42764-023-00109-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42764-023-00109-1